tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Sanofi Consumer Healthcare India Approves Q3 2025 Financial Results

Story Highlights
Sanofi Consumer Healthcare India Approves Q3 2025 Financial Results

TipRanks Black Friday Sale

Sanofi Consumer Healthcare India Limited ( (IN:SANOFICONR) ) just unveiled an update.

Sanofi Consumer Healthcare India Limited announced the approval of its unaudited financial results for the quarter and nine months ending September 30, 2025, during a board meeting held on November 12, 2025. The results, reviewed by the audit committee, adhere to Indian Accounting Standards and will be published in compliance with SEBI regulations. This announcement is significant for stakeholders as it reflects the company’s financial health and compliance with regulatory standards.

More about Sanofi Consumer Healthcare India Limited

Sanofi Consumer Healthcare India Limited operates in the healthcare industry, focusing on consumer healthcare products. The company is part of the larger Sanofi group, which is known for its pharmaceutical and healthcare solutions, catering to various consumer health needs.

Average Trading Volume: 227

Technical Sentiment Signal: Strong Sell

Current Market Cap: 106.5B INR

For an in-depth examination of SANOFICONR stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1